↓
 

Money Matters TV 24-42 Shah

Money Matters TV Posted on by

Kimon Hatza, Esq. of GrowthCounsel interviews Nikej N. Shah, M.D., CEO of Nirsum Laboratories about issues in Long-term opioid therapy: Unmet needs, Risks and Solutions with a new drug in Phase I testing with the FDA. Present drugs in use today are Bupremorphine, Methadone and Maltrexone.

Podcast: Play in new window | Download

Comments

Money Matters TV 24-42 Shah — No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

HTML tags allowed in your comment: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

↑